Gilead Sciences Inc (NASDAQ:GILD)

Data as of Nov 26
 -0.81 / -0.80%
Today’s Change
Today|||52-Week Range
Johnson & Johnson's Rezolsta Approved in the EU for HIV-1 - Analyst Blog
1:56pm /
Get Your Wallet Out: Global Drug Spending is About to Hit a Dubious Milestone
Nov 23 /
#PreMarket Primer: Wednesday, November 26: Big Retailers Gear Up For Black Friday
Nov 26 / Benzinga
This May Be the Fastest Growing Big Biotech Stock Next Year (Hint: It's Not Gilead Sc...
Nov 22 /
Friday Sector Leaders: Healthcare, Utilities
Nov 26 /
Buy Gilead Sciences
Nov 21 /
Should Gilead Sciences, Inc. Pay a Dividend?
Nov 26 /
Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog
Nov 20 /
Dow Chemical, NXP Semi, Gilead Sciences Set for Gains, Lucia Capital CEO Says
Nov 25 /
Biotech's 3 Most Influential CEOs
Nov 20 /
3 Stocks Underperforming Today In The Drugs Industry
Nov 25 /
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
Nov 19 /
3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie
Nov 25 /
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in th...
Nov 19 /
Why You Shouldn't Bet Against Gilead Sciences (GILD) Stock - Tale of the Tape
Nov 25 /
Stock Market News for November 19, 2014 - Market News
Nov 19 /
3 Biotech Growth Stocks You Can Buy Right Now
Nov 25 /
Stock Market News for November 17, 2014 - Market News
Nov 17 /
AbbVie Takes Aim at Gilead Sciences
Nov 25 /
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
Nov 17 /
Nations thrive by uniting professors and entrepreneurs
Nov 25 /
3 Stocks the Smartest Investors Are Buying Right Now
Nov 17 /
'Mad Money' Lightning Round: I Think Twitter Needs a New CEO
Nov 25 /
The Fab 5 Update
Nov 15 / StockTwits
AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog
Nov 24 /
Trading Activity
Nov 14 / StockTwits
3 Biotech Stocks That Could Soar Even Higher
Nov 24 /
October jitters are just a taste things to come
Nov 10 /
3 Stocks Reiterated As A Buy: UNH, QCOM, GILD
Nov 24 /
Gilead Sciences Popular Amongst Latest 13F Filers
Oct 31 /
Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year
Nov 24 /
Electronic Arts climbs on strong earnings
Oct 29 /
November 28 Weekly Option Expiration Plan
Nov 23 / StockTwits
Gilead's latest hepatitis C drug breaks US sales records
Oct 28 /

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.